AR

Ardelyx

- NASDAQ:ARDX
Last Updated 2024-04-23
  • Ardelyx develops novel oral therapeutics to treat mineral metabolism and metabolic disorders.

  • Locations

    • Fremont CA

  • Total Funding (USD)

    298.9 million

  • Industries

    Real Estate, Mobile Apps, Software, Cyber Security

  • Security

    Type: ORD
    CUSIP: 039697107
    ISIN: US0396971071
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.

Request Demo